View our latest Ask an Expert series about HLA Biomarkers in Cancer Immunotherapy: Current Evidence & Emerging Direction hosted by Doug Rains with Paul Childress.
Paul Childress, PhD, joined moderator Doug Rains for a focused 30-minute session exploring the role of HLA biomarkers in cancer immunotherapy. The discussion covered current applications, emerging evidence, and practical insights for oncology trial planning.